Bhutan vs Landlocked developing countries (LLDCs): Proportion of the target population who received the final dose of
Bhutan
92.0%
in 2024
Landlocked developing countries (LLDCs)
44.0%
in 2024
Bhutan rank
6th
Landlocked developing countries (LLDCs) rank
17th
Proportion of the target population who received the final dose of over time
- Bhutan
- Landlocked developing countries (LLDCs)
How they compare
Bhutan currently reports 92.0% against 44.0% in Landlocked developing countries (LLDCs), a difference of 48.0%.
That makes Bhutan's figure about 2.1 times Landlocked developing countries (LLDCs)'s.
Across all 15 years both countries report, Bhutan has been ahead every year.
Bhutan ranks 6th and Landlocked developing countries (LLDCs) ranks 17th of 107 countries.
Bhutan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Landlocked developing countries (LLDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.5% | 5.3% | 81.2% | Bhutan |
| 2020s | 86.0% | 28.2% | 57.8% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Bhutan or Landlocked developing countries (LLDCs)?
- Bhutan, at 92.0% against 44.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Bhutan and Landlocked developing countries (LLDCs)?
- 48.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Landlocked developing countries (LLDCs)?
- 15 years are reported by both, from 2010 to 2024.
- How do Bhutan and Landlocked developing countries (LLDCs) rank globally for proportion of the target population who received the final dose of?
- Bhutan ranks 6th and Landlocked developing countries (LLDCs) ranks 17th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.